Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP612733.RAhl5tpCygZ_40_y3vAMMlOUEK8K8dr2E2p2w9vEsulJM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP612733.RAhl5tpCygZ_40_y3vAMMlOUEK8K8dr2E2p2w9vEsulJM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP612733.RAhl5tpCygZ_40_y3vAMMlOUEK8K8dr2E2p2w9vEsulJM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP612733.RAhl5tpCygZ_40_y3vAMMlOUEK8K8dr2E2p2w9vEsulJM130_provenance.
- NP612733.RAhl5tpCygZ_40_y3vAMMlOUEK8K8dr2E2p2w9vEsulJM130_assertion description "[Interferon-beta (IFN-beta) is routinely prescribed as an immunomodulatory treatment for multiple sclerosis (MS), but is associated with variable clinical efficacy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP612733.RAhl5tpCygZ_40_y3vAMMlOUEK8K8dr2E2p2w9vEsulJM130_provenance.
- NP612733.RAhl5tpCygZ_40_y3vAMMlOUEK8K8dr2E2p2w9vEsulJM130_assertion evidence source_evidence_literature NP612733.RAhl5tpCygZ_40_y3vAMMlOUEK8K8dr2E2p2w9vEsulJM130_provenance.
- NP612733.RAhl5tpCygZ_40_y3vAMMlOUEK8K8dr2E2p2w9vEsulJM130_assertion SIO_000772 17540610 NP612733.RAhl5tpCygZ_40_y3vAMMlOUEK8K8dr2E2p2w9vEsulJM130_provenance.
- NP612733.RAhl5tpCygZ_40_y3vAMMlOUEK8K8dr2E2p2w9vEsulJM130_assertion wasDerivedFrom befree-2016 NP612733.RAhl5tpCygZ_40_y3vAMMlOUEK8K8dr2E2p2w9vEsulJM130_provenance.
- NP612733.RAhl5tpCygZ_40_y3vAMMlOUEK8K8dr2E2p2w9vEsulJM130_assertion wasGeneratedBy ECO_0000203 NP612733.RAhl5tpCygZ_40_y3vAMMlOUEK8K8dr2E2p2w9vEsulJM130_provenance.
- befree-2016 importedOn "2016-02-19" NP612733.RAhl5tpCygZ_40_y3vAMMlOUEK8K8dr2E2p2w9vEsulJM130_provenance.